Jpmorgan Chase & Co »

Vistagen Therapeutics Ord shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $48 16 3.00
2024-06-30 $56 16 3.50
2024-03-31 $84 16 5.25
2023-12-31 $82 16 5.13
2023-09-30 $84 16 5.25
2023-06-30 $898 481 1.87

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Vistagen Therapeutics Ord

BVF
Stempoint Capital
Vanguard Group
Commodore Capital
Nantahala Capital Management
Sphera Funds Management
Dr. Jeffrey R. Jay, M.D.
BlackRock
BlackRock
Citadel Advisors
Armistice Capital
Geode Capital Management
Susquehanna International
Renaissance Technologies
Goldman Sachs Group

View all funds holding Vistagen Therapeutics Ord